# Clinical Response to Rhinovirus Challenge

> **NCT02910401** · PHASE2 · COMPLETED · sponsor: **University of Virginia** · enrollment: 38 (actual)

## Conditions studied

- Asthma
- Allergic Rhinitis

## Interventions

- **BIOLOGICAL:** Rhinovirus (GMP RV16 HRV-16)

## Key facts

- **NCT ID:** NCT02910401
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2022-09-21
- **Final completion:** 2022-09-21
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2024-01-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02910401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02910401, "Clinical Response to Rhinovirus Challenge". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02910401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*